(Q38037486)

27 August 2017

Melanoma as a model tumour for immuno-oncology (English)

1 reference

27 August 2017

1

1 reference

27 August 2017

1 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

23 Suppl 8

1 reference

27 August 2017

viii10-4

1 reference

Estimates of cancer incidence and mortality in Europe in 2008.

27 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Immunity against cancer: lessons learned from melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

T-cell recognition of melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

The biology of cancer testis antigens: putative function, regulation and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Human tumor antigens recognized by T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Spontaneous regression of metastases from melanoma: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Spontaneous regression of melanoma may offer insight into cancer immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Tumor immunoediting and immunosculpting pathways to cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Autoimmune melanocyte destruction in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Management of metastatic melanoma: nursing challenges today and tomorrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Autoimmunity associated with immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

The impact of retrotransposons on human genome evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS257

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS257

1 reference

27 August 2017

1 reference

PubMed ID

22918922